AI summary · may contain errors
High-risk HPV DNA was detected in 31.4% of 191 women living with HIV attending Connaught Teaching Hospital in Freetown, with HPV 52 most common and only 30% carrying 16/18.
- Open access
Moving in medRxiv, The Lancet Global Health, JNCI: Journal of the National Cancer Institute, The Lancet Oncology, JAMA, JAMA Internal Medicine and The Lancet Infectious Diseases.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
High-risk HPV DNA was detected in 31.4% of 191 women living with HIV attending Connaught Teaching Hospital in Freetown, with HPV 52 most common and only 30% carrying 16/18.
AI summary · may contain errors
Breast cancer research and treatment are reviewed in a Healthy Dialogue podcast featuring Derek C. Angus and Nancy E. Davidson, focusing on the field’s history and future directions.
AI summary · may contain errors
A one-time HPV catch-up vaccination campaign targeting females aged 9-30 in 132 LMICs could prevent nearly 7 million cervical cancer cases and over 3.5 million deaths, with cost-effectiveness varying by country.
AI summary · may contain errors
In 2022, global cervical cancer screening coverage for women aged 30–49 years using any method was 35% (30–39) over the previous 5 years, with 38% ever screened.
AI summary · may contain errors
Breast cancer deaths among Brazilian women increased from 7,085 in 1996 to 20,849 in 2024, with age-standardized mortality rising from 11.4 to 14.3 per 100,000.
Journals this month
Topics moving, week to 17 Nov 2026
By field